SM
TDOC icon

SG3 Management’s Teladoc Health TDOC Stock Holding History

SG3 Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,000
Closed -$289K – 812
2022
Q1 		$289K Hold
4,000
– – 0.01% 703
2021
Q4 		$367K Sell
4,000
-12,500
-76% -$1.49M 0.01% 705
2021
Q3 		$2.09M Hold
16,500
– – 0.06% 289
2021
Q2 		$2.74M Hold
16,500
– – 0.1% 237
2021
Q1 		$3M Buy
16,500
+7,500
+83% +$1.74M 0.08% 304
2020
Q4 		$1.8M Buy
+9,000
New +$1.83M 0.03% 412

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

SG3 Management's TDOC Position: Q2 2022 in Review

SG3 Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,000 shares — an estimated $289K sold.

SG3 Management first reported a position in TDOC in Q3 2020 and held it in 5 quarters. The position peaked at $1.08M in Q3 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • SG3 Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 4,000 Teladoc Health shares in Q2 2022, an estimated $289K.
  • SG3 Management first reported a position in Teladoc Health in Q3 2020 and held it in 5 quarters.
  • SG3 Management's Teladoc Health position peaked at $1.08M in Q3 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.